Researchers at the Medical University of South Carolina (MUSC) report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after ...
Oct 26, 2021
0
5
A new national report released today highlights a decline in hepatitis C testing and treatment uptake, putting Australia at risk of not achieving its target of eliminating hepatitis C as a public health threat by 2030.
Oct 25, 2021
0
4
The risk of HIV or hepatitis C in people who inject drugs is influenced as much by their social interactions and the venues where they inject as other risk factors, according to a study published today in eLife.
Aug 3, 2021
0
200
A newly published Burnet Institute study has demonstrated the feasibility and effectiveness of simplified clinical pathways for treatment of hepatitis C (HCV) in Myanmar.
Jul 28, 2021
0
6
Survival rates after a heart transplant are unaffected if the organ donor had used illicit drugs or died due to an overdose, a fact that is increasing the availability of hearts due to the rise in drug overdose deaths in ...
Jul 28, 2021
0
47
There's a good reason why hepatitis C is known as a "silent killer."
Jul 20, 2021
0
3
A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other scientists for discovering ...
Jul 12, 2021
0
11
(HealthDay)—Health care providers should test liver recipients for hepatitis B virus (HBV) given the slight risk for unexpected donor-derived HBV infection, according to research published in the July 9 issue of the U.S. ...
Jul 12, 2021
0
0
While the risk of hepatocellular carcinoma (HCC) – primary liver cancer—is higher among patients who have HIV, it's even higher among patients who have HIV and detectable hepatitis B, according to research from the Perelman ...
May 21, 2021
0
10
Untreated hepatitis C can lead to serious and life-threatening health problems like cirrhosis and liver cancer. Direct-acting antiviral therapies introduced in recent years are highly effective, with cure rates above 95%.
May 20, 2021
0
2
